发明公开
EP2628481A1 Trisubstituted heterocycles as replication inhibitors of hepatitis C virus HCV
有权
Trisubstituierte Heterocyclen als Inhibitoren der Hepatitis C Virus HCV Replikation
- 专利标题： Trisubstituted heterocycles as replication inhibitors of hepatitis C virus HCV
- 专利标题（中）： Trisubstituierte Heterocyclen als Inhibitoren der Hepatitis C Virus HCV Replikation
-
申请号： EP13167828.6申请日： 2010-06-10
-
公开(公告)号： EP2628481A1公开(公告)日： 2013-08-21
- 发明人: Randolph, John T. , Degoey, David A. , Kati, Warren M. , Hutchins, Charles W. , Donner, Pamela L. , Krueger Allan C. , Motter, Christopher E. , Nelson, Lissa T. , Patel, Sachin V. , Matulenko, Mark A. , Keddy, Ryan G. , Jinkerson, Tammie K. , Hutchinson Douglas K. , Flentge, Charles A. , Wagner, Rolf , Maring, Clarence J. , Tufano, Michael D. , Betebenner, David A. , Rockway, Todd W. , Liu, Dachun , Pratt, John K. , Sarris, Kathy , Woller, Kevin R. , Wagaw, Seble H. , Califano, Jean C. , Li, Wenke , Caspi, Daniel.D. , Bellizzi, Mary, E. , Gao, Yi
- 申请人： AbbVie Bahamas Ltd.
- 申请人地址： Sassoon House Shirley Street & Victoria Avenue New Providence, Nassau BS
- 专利权人： AbbVie Bahamas Ltd.
- 当前专利权人： AbbVie Bahamas Ltd.
- 当前专利权人地址： Sassoon House Shirley Street & Victoria Avenue New Providence, Nassau BS
- 代理机构： Modiano, Micaela Nadia
- 优先权： US186291P 20090611; US242836P 20090916; US243596P 20090918
- 主分类号： A61K31/4025
- IPC分类号： A61K31/4025 ; A61K31/4178 ; A61K31/4184 ; A61K31/4439 ; A61P31/14 ; C07D401/14 ; C07D417/14 ; C07D403/14
摘要：
Compounds effective in inhibiting replication of Hepatitis C virus ("HCV") are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.
公开/授权文献
信息查询
IPC分类:
